Accuracy of the CoaguChek XS for point-of-care international normalized ratio (INR) measurement in children requiring warfarin

Thrombosis and Haemostasis

Volumn 99, Issue 6, 2008, Pages 1097-1103

  Bauman, Mary E ^a,c   Black, Karina L ^a   Massicotte, Mary P ^a   Bauman, Michelle L ^a   Kuhle, Stefan ^a   Howlett Clyne, Susan ^b   Cembrowski, George S ^b   Bajzar, Laszlo ^a  

^a UNIVERSITY OF ALBERTA   (Canada)

^b UNIVERSITY OF ALBERTA HOSPITAL   (Canada)

^c STOLLERY CHILDREN S HOSPITAL   (Canada)

Author keywords

Child; Home monitoring; International normalized ratio; Point of care; Warfarin

Indexed keywords

PROTHROMBIN; WARFARIN;

ACCURACY; ADOLESCENT; ARTICLE; BLOOD SAMPLING; CHILD; CONGESTIVE CARDIOMYOPATHY; CONTROLLED STUDY; DEEP VEIN THROMBOSIS; GOLD STANDARD; HUMAN; INTERNATIONAL NORMALIZED RATIO; MAJOR CLINICAL STUDY; MONITOR; MUCOCUTANEOUS LYMPH NODE SYNDROME; PLASMA; POINT OF CARE TESTING; PRIORITY JOURNAL; STATISTICAL ANALYSIS; VENOUS BLOOD;

ADMINISTRATION, ORAL; ADOLESCENT; ANTICOAGULANTS; BLOOD COAGULATION; CHILD; CHILD, PRESCHOOL; DRUG MONITORING; EQUIPMENT DESIGN; HUMANS; INFANT; INTERNATIONAL NORMALIZED RATIO; POINT-OF-CARE SYSTEMS; PREDICTIVE VALUE OF TESTS; REPRODUCIBILITY OF RESULTS; WARFARIN;

EID: 44949224965     PISSN: 03406245     EISSN: None     Source Type: Journal    
DOI: 10.1160/TH07-10-0634     Document Type: Article

References (38)

1. Streif W, Andrew M, Marzinotto V, et al. Analysis of warfarin therapy in pediatric patients: A prospective cohort study of 319 patients. Blood 1999; 94: 3007-3014.
2. Andrew M, Marzinotto V, Brooker LA, et al. Oral anticoagulation therapy in pediatric patients: a prospective study. Thromb Haemost 1994; 71: 265-269.
3. Errichetti AM, Holden A, Ansell J. Management of oral anticoagulant therapy. Experience with an anticoagulation clinic. Arch Intern Med 1984; 144: 1966-1968.
4. Michelson AD, Bovill E, Monagle P, et al. Antithrombotic therapy in children. Chest 1998; 114 (5 Suppl): 748S-769S.
5. Monagle P, Chan A, Massicotte P, et al. Antithrombotic therapy in children: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. Chest 2004; 126 (3 Suppl): 645S-687S.
6. Hamilton JG. Needle phobia: a neglected diagnosis. J Family Pract 1995; 41: 169-175.
7. Newall F, Bauman M. Point-of-care monitoring of anticoagulant therapy in paediatric patients. Prog Pediatric Cardiol 2005; 21: 53-61.
8. Newall F, Bauman M. Point-of-care antithrombotic monitoring in children. Thromb Res 2006; 118: 113-121.
9. Reiss N, Blanz U, Breymann T, et al. Mechanical valve replacement of the systemic atrioventricular valve in children. ASAIO J 2006; 52: 559-561.
10. Christensen TD. Self-management of oral anticoagulant therapy: a review. J Thromb Thrombolysis 2004; 18: 127-143.
11. Christensen TD, Attermann J, Hjortdal VE, et al. Self-management of oral anticoagulation in children with congenital heart disease. Cardiol Young 2001; 11: 269-276.
12. Mahonen S, Riikonen P, Vaatainen RL, et al. Oral anticoagulant treatment in children based on monitoring at home. Acta Paediatrica 2004; 93: 687-691.
13. Massicotte P, Marzinotto V, Vegh P, et al. Home monitoring of warfarin therapy in children with a whole blood prothrombin time monitor. J Pediatrics 1995; 127: 389-394.
14. Newall F, Monagle P, Johnston L. Home INR monitoring of oral anticoagulant therapy in children using the CoaguChektrade mark S point-of-care monitor and a robust education program. Thromb Res 2006; 118: 587-593.
15. Nowatzke W, Landt M, Smith C, et al. Whole blood international normalization ratio measurements in children using near-patient monitors. J Pediatric Hematol/Oncol 2003; 25: 33-37.
16. Gunther T, Mazzitelli D, Schreiber C, et al. Mitralvalve replacement in children under 6 years of age. Europ J Cardio Thorac Surg 2000; 17: 426-430.
17. Andrew M, Ansell J, Becker D, et al. Multi-center trial of accurate home self testingin oral anticoagulant patients with a novel whole blood system. Blood 1996; 88: 179a.
18. Christensen TD, Andersen NT, Attermann J, et al. Mechanical heart valve patients can manage oral anticoagulant therapy themselves. Europ J Cardio Thorac Surg 2003; 23: 292-298.
19. Marzinotto V, Monagle P, Chan A, et al. Capillary whole blood monitoring of oral anticoagulants in children in outpatient clinics and the home setting. Pediatric Cardiol 2000; 21: 347-352.
20. Hill J, Perreault S, Dorval M. Validity of Coagu-Chek S for home monitoring of anticoagulant therapy in pediatrics. Can J Cardiol 2007; 23: 47-50.
21. Ignjatovic V, Barnes C, Newall F, et al. Point of care monitoring of oral anticoagulant therapy in children: comparison of CoaguChek Plus and Thrombotest methods with venous international normalised ratio. Thromb Haemost 2004; 92: 734-737.
22. WHO. Guidelines for thromboplastins and plasmas used to control anticoagulant therapy. Technical Report Series 1999.
23. Evaluation of the CoaguChek XS System. International Evaluation Workshop; 2005; Heidelberg, Germany.
24. Braun S, Watzke H, Hasenkam JM, et al. Performance evaluation of the new CoaguChek XS system compared with the established CoaguChek system by patients experienced in INR-self management. Thromb Haemost 2007; 97: 310-314.
25. Leichsenring I, Plesch W, Unkrig V, et al. Multicentre ISI assignment and calibration of the INR measuring range of a new point-of-care system designed for home monitoring of oral anticoagulation therapy. Thromb Haemost 2007; 97: 856-861.
26. Bauman M, Massicotte M, Ray L, et al. Developing educational materials to facilitate adherence; Pediatric thrombosis as a case illustration. J Ped Health Care 2007; 21: 198-206.
27. Cembrowski G, Martindale R. Quality Control and Statistics. Philadelphia: Lippincott, Williams & Wilkins, 2005.
28. Shermock KM, Bragg L, Connor JT, et al. Differences in warfarin dosing decisions based on international normalized ratio measurements with two point-of-care testing devices and a reference laboratory measurement. Pharmacotherapy 2002; 22: 1397-1404.
29. Fitzmaurice DA, Machin SJ, British Society of Haematology Task Force for Haemostasis and Thrombosis. Recommendations for patients undertaking self management of oral anticoagulation. Br Med J 2001; 323: 985-989.
30. Douketis JD, Lane A, Milne J, et al. Accuracy of a portable International Normalization Ratio monitor in outpatients receiving long-term oral anticoagulant therapy: comparison with a laboratory reference standard using clinically relevant criteria for agreement. Thromb Res 1998; 92: 11-17.
31. Lassen JF, Kjeldsen J, Antonsen S, et al. Intepretation of serial measurements of international normalized ratio for prothrombin times in monitoring oral anticoagulant therapy. Clin Chem 1995; 41: 1171-1176.
32. Bussey HI, Chiquette E, Bianco TM, et al. A statistical and clinical evaluation of fingerstick and routine laboratory prothrombin time measurements. Pharmacotherapy 1997; 17: 861-866.
33. Anderson DR, Harrison L, Hirsh J. Evaluation of a portable prothrombin time monitor for home use by patients who require long-term oral anticoagulant therapy. Arch Intern Med 1993; 153: 1441-1447.
34. Howlett-Clyne S, Cembrowski G, Etches W, et al. Comparison of the performance of the Raoche coaugu-Chek XS and CoaugChek S using 'just in time' appraisals of factory issued PT-INR self-monitorin systems. Int J Lab Hematol 2007; 29: 96-97.
35. Bland JM, Altman DG. Statistical methods for assessing agreement between two methods of clinical measurement. Lancet 1986; 1: 307-310.
36. Bereznicki LR, Jackson SL, Peterson GM, et al. Accuracy and clinical utility of the CoaguChek XS portable international normalised ratio monitor in a pilot study of warfarin home-monitoring. J Clin Pathol 2007; 60: 311-314.
37. Douketis JD. Patient self-monitoring of oral anticoagulant therapy: potential benefits and implications for clinical practice. Am J Cardiovasc Drugs 2001; 1: 245-251.
38. Kitchen S, Kitchen DP, Jennings I, et al. Point-ofcare International Normalised Ratios: UK NEQAS experience demonstrates necessity for proficiency testing of three different monitors. Thromb Haemost 2006; 96: 590-596.